Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Crizotinib Capsules 200mg, 250mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 200mg, 250mg

Reference Brands: Xalkori (US/EU)

Category: Oncology Cancer Care

Crizotinib is the generic for the trade chemotherapy drug Xalkori. In some cases, health care professionals may use the trade name Xalkori when referring to the generic drug name crizotinib. Drug type: Crizotinib is a targeted therapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Crizotinib Capsules — third party manufacturing & bulk supply

Crizotinib Capsules 200mg, 250mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Crizotinib Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Crizotinib Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Crizotinib Capsules →
Back to Listing

Frequently Asked Questions

Crizotinib Capsules is listed as Capsules in 200mg, 250mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Crizotinib Capsules is referenced against Xalkori (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Osimertinib Tablets

Strength:
40 mg, 80 mg

Form: Tablets

Reference Brands: Tagrisso (USA/EU)

View Details
Palbociclib Tablet

Strength:
75mg, 100mg, 125mg

Form: Tablets

Reference Brands:

View Details
Venetoclax Tablet

Strength:
50mg, 100mg

Form: Tablets

Reference Brands:

View Details
Ixazomib Capsule

Strength:
2.3mg, 3mg, 4mg

Form: Capsules

Reference Brands: Ninlaro (US/EU)

View Details
Lenalidomide Capsule

Strength:
2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg

Form: Oral Capsules

Reference Brands: Revlimid® (EU & US)

View Details
Lenvatinib

Strength:
4 mg , 10 mg

Form: Oral capsules

Reference Brands: Lenvima® (EU & US)

View Details
Letrozole

Strength:
2.5 mg

Form: Tablets

Reference Brands: Femara® (US & EU)

View Details
Methotrexate

Strength:
Tablets: 2.5 mg, 5 mg, 10 mg, 15 mg; IV/IM: 25 mg/mL

Form: Oral tablets, Injection (IV and IM)

Reference Brands: Trexall®, Rheumatrex® (EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.